RecruitingPhase 1NCT06567769

Phase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA)

Studying Sanfilippo syndrome type A

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: GC Biopharma Corp
Intervention: GC1130A(drug)
Enrollment: 9 enrolled
Eligibility: 18 years · All sexes
Timeline: 2024 – 2027

Study locations (5)

UCSF Benioff Children's Hospital, Oakland, California, United States
University of Minnesota, Minneapolis, Minnesota, United States
National Center for Child Health and Development, Setagaya City, Tokyo, Japan
Ajou University Medical Center, Suwon, Gyeongi-do, South Korea
Samsung Medical Center, Seoul, South Korea

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06567769 on ClinicalTrials.gov

← Back to all trials